Literature DB >> 16402906

Regulation of platelet functions by P2 receptors.

Christian Gachet1.   

Abstract

The main role of blood platelets is to ensure primary hemostasis, which is the maintenance of vessel integrity and cessation of bleeding upon injury. While playing a major part in acute arterial thrombosis, platelets are also involved in inflammation, atherosclerosis, and angiogenesis. ADP and ATP play a crucial role in platelet activation, and their receptors are potential targets for antithrombotic drugs. The ATP-gated cation channel P2X(1) and the two G protein-coupled ADP receptors, P2Y(1) and P2Y(12), selectively contribute to platelet aggregation and formation of a thrombus. Owing to its central role in the growth and stabilization of a thrombus, the P2Y(12) receptor is an established target of antithrombotic drugs such as clopidogrel. Studies in P2Y(1) and P2X(1) knockout mice and selective P2Y(1) and P2X(1) antagonists have shown that these receptors are also attractive targets for new antithrombotic compounds. The potential role of platelet P(2) receptors in the involvement of platelets in inflammatory processes is also discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16402906     DOI: 10.1146/annurev.pharmtox.46.120604.141207

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  74 in total

Review 1.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

2.  Discovery of purinergic signalling, the initial resistance and current explosion of interest.

Authors:  G Burnstock
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 3.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

4.  High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.

Authors:  Amala P Chirumamilla; Akiko Maehara; Gary S Mintz; Roxana Mehran; Sunil Kanwal; Giora Weisz; Ahmed Hassanin; Diaa Hakim; Ning Guo; Usman Baber; Robert Pyo; Jeffrey W Moses; Martin Fahy; Jason C Kovacic; George D Dangas
Journal:  JACC Cardiovasc Imaging       Date:  2012-05

5.  Intravascular ADP and soluble nucleotidases contribute to acute prothrombotic state during vigorous exercise in humans.

Authors:  Gennady G Yegutkin; Sergei S Samburski; Stefan P Mortensen; Sirpa Jalkanen; José González-Alonso
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

6.  Increased sensitivity to extracellular ATP of fibroblasts from patients affected by systemic sclerosis.

Authors:  Andrea Lo Monaco; Sara Gulinelli; Gabriella Castellino; Anna Solini; Davide Ferrari; Renato La Corte; Francesco Trotta; Francesco Di Virgilio
Journal:  Ann Rheum Dis       Date:  2007-08       Impact factor: 19.103

7.  P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions.

Authors:  S F Maloney; Lawrence F Brass; S L Diamond
Journal:  Integr Biol (Camb)       Date:  2010-01-05       Impact factor: 2.192

8.  The phenotypic legacy of admixture between modern humans and Neandertals.

Authors:  Corinne N Simonti; Benjamin Vernot; Lisa Bastarache; Erwin Bottinger; David S Carrell; Rex L Chisholm; David R Crosslin; Scott J Hebbring; Gail P Jarvik; Iftikhar J Kullo; Rongling Li; Jyotishman Pathak; Marylyn D Ritchie; Dan M Roden; Shefali S Verma; Gerard Tromp; Jeffrey D Prato; William S Bush; Joshua M Akey; Joshua C Denny; John A Capra
Journal:  Science       Date:  2016-02-12       Impact factor: 47.728

9.  Human P2Y(14) receptor agonists: truncation of the hexose moiety of uridine-5'-diphosphoglucose and its replacement with alkyl and aryl groups.

Authors:  Arijit Das; Hyojin Ko; Lauren E Burianek; Matthew O Barrett; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

10.  Characterization of a new peptide agonist of the protease-activated receptor-1.

Authors:  Yingying Mao; Jianguo Jin; Satya P Kunapuli
Journal:  Biochem Pharmacol       Date:  2007-09-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.